Raymond James Downgrades Meridian Biosciences (VIVO) to Market Perform
VIVO Hot Sheet
Rating Summary:2 Buy, 1 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Raymond James downgraded Meridian Biosciences (NASDAQ: VIVO) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $18.02 yesterday, with a 52 week range of $14.81-$27.37.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $18.02 yesterday, with a 52 week range of $14.81-$27.37.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Caris & Co. Downgrades Viacom (VIA) to Above Average
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
